Neuronetics (NASDAQ: STIM) reported Q4 EPS of ($0.10), $0.01 worse than the analyst estimate of ($0.09). Revenue for the quarter came in at $41.77 million versus the consensus estimate of $40.66 million.

GUIDANCE:

Neuronetics sees FY2026 revenue of $160-166 million, versus the consensus of $164.2 million.

For earnings history and earnings-related data on Neuronetics (STIM) click here.